Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies

NCT05240690 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Pancreatic Cancer
Hepatocellular Carcinoma , Cholangiocarcinoma

Interventions

BIOLOGICAL: Umbilical Cord Blood Derived MAK Immune Cells

Sponsor

Zhou Fuxiang